Notice of Intent to Sole Source – Metabolon Inc.

The Medical University of South Carolina issued a Notice of Intent to Sole Source a contract to Metabolon Inc. for specialized metabolomic analysis services supporting a research study on pre‑eclampsia in women with Type 1 diabetes. The study will analyze 177 longitudinal plasma samples, requiring untargeted metabolomic profiling, data interpretation, and biomarker identification using Metabolon’s proprietary reference library and analytical workflow. Because Metabolon’s unique combination of patented technologies, extensive metabolite database, and expert interpretation cannot be obtained elsewhere, the university seeks a sole‑source award valued at $143,361. • Scope: untargeted metabolomic analysis of 177 plasma samples, including data processing and biological interpretation. • Sole‑source justification: exclusive proprietary metabolite library (>5,400 metabolites), patented chemocentric methodology, and specialized interpretive services. • Procurement details: Notice published Oct 9 2026; interested parties must notify by Oct 19 2026; contract amount $143,361; procurement manager Leigh Gileno.